MIR-221/MDM2/P53 CONTROL LOOP SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO ANTI-CANCER TREATMENTS

被引：1
|
作者：
Fornari, F. [1 ]
Milazzo, M. [1 ]
Giovannini, C. [1 ]
Galassi, M. [1 ]
Negrini, M. [2 ]
Gramantieri, L. [1 ]
Bolondi, L. [1 ]
机构：
[1] S Orsola Malpighi Univ Hosp, Bologna, Italy
[2] Univ Ferrara, I-44100 Ferrara, Italy
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60284-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
271
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma
    Fornari, Francesca
    Milazzo, Maddalena
    Galassi, Marzia
    Callegari, Elisa
    Veronese, Angelo
    Miyaaki, Hisamitsu
    Sabbioni, Silvia
    Mantovani, Vilma
    Marasco, Elena
    Chieco, Pasquale
    Negrini, Massimo
    Bolondi, Luigi
    Gramantieri, Laura
    MOLECULAR CANCER RESEARCH, 2014, 12 (02) : 203 - 216
  • [2] Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
    Giovannini, Catia
    Minguzzi, Manuela
    Baglioni, Michele
    Fornari, Francesca
    Giannone, Ferdinando
    Ravaioli, Matteo
    Cescon, Matteo
    Chieco, Pasquale
    Bolondi, Luigi
    Gramantieri, Laura
    ONCOTARGET, 2014, 5 (21) : 10607 - 10620
  • [3] miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/ MDM2 feedback loop
    Chen, Qiudan
    Wang, Weifeng
    Chen, Shuying
    Chen, Xiaotong
    Lin, Yong
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2021, 26 (01)
  • [4] miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop
    Qiudan Chen
    Weifeng Wang
    Shuying Chen
    Xiaotong Chen
    Yong Lin
    Cellular & Molecular Biology Letters, 2021, 26
  • [5] PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy
    Mayo, LD
    Dixon, JE
    Durden, DL
    Tonks, NK
    Donner, DB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) : 5484 - 5489
  • [6] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma
    Jablkowski, M
    Bocian, A
    Bialkowska, J
    Bartkowiak, J
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (01): : 117 - 125
  • [7] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    Oncogene, 1999, 18 : 1921 - 1934
  • [8] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    ONCOGENE, 1999, 18 (11) : 1921 - 1934
  • [9] The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation
    Hui Cao
    Xiaosong Chen
    Zhijun Wang
    Lei Wang
    Qiang Xia
    Wei Zhang
    Cell Death Discovery, 6
  • [10] Alterations of P53 and MDM2 correlate with advanced stage of hepatocellular carcinoma
    Zhang, X
    Beckebaum, S
    Worm, K
    Frilling, A
    Schmid, KW
    Broelsch, CE
    Gerken, G
    Cicinnati, VR
    JOURNAL OF HEPATOLOGY, 2004, 40 : 86 - 87
12345